Thymalin
The Quiet Immune Peptide for the Thymus Gland
Thymalin is not a single molecule. It is an extract, a complex of short peptides drawn from the thymus gland of calves, and it has been used for decades to support the immune system as the thymus fades with age.
It comes from a well-known lineage: the Russian peptide-bioregulator program in St. Petersburg, the same research group behind Epitalon. In our practice, thymalin is not a peptide people feel. It works in the background, on the immune system, over the long term.
.svg)
What we've seen in practice
Thymalin is one of our quiet, foundational peptides, and Dr. Koniver is upfront about that. His comparison is a vitamin D3 supplement: you do not notice it while it is there, but you would notice if it were gone. It does not produce the kind of result a patient calls about. Nobody reports feeling suddenly energized or sleeping better on it. What it does, it does in the background, on the immune system, and that is exactly why we value it.
The target is the thymus gland, a small endocrine gland that sits behind the breastbone in the middle of the chest. It is central to training the immune system early in life, and it shrinks as we age, a process some researchers believe helps drive aging itself. Thymalin is aimed at supporting that gland and the immune balance it governs. Dr. Koniver treats it as a long-term play rather than a quick intervention, and he considers it very safe.
Thymalin at a glance
A peptide extract, not a single molecule: a complex of short peptides from calf thymus gland, one of the Russian peptide bioregulators
.svg)
Immune support and restoration, especially age-related immune decline; the research base also covers infection recovery and geroprotection
.svg)
Real but concentrated in one research program and mostly Russian; a multi-year human study reported lower mortality, and modern lab work supports the anti-inflammatory activity; no large Western trials[1, 2]
.svg)
By injection (intramuscular or subcutaneous)
.svg)
A heterogeneous mixture, not a defined sequence; short peptides in roughly the 1,000 to 10,000 dalton range; no single formula[3]
Not FDA-approved; approved and used in Russia; not named by WADA. Details below
A quiet, background immune-support peptide we keep on board across many protocols. See what we have seen in practice above
Thymalin is a mixture of short thymic peptides, not one defined chain, which is why there is no single formula or bead sequence to draw.
Why there is no formula on this page. Almost every directory entry has a molecular formula and a defined sequence. Thymalin does not, and that is not an omission: it is an extract, a mixture of short peptides pulled from thymus tissue rather than one manufactured molecule, so it has a weight range instead of a single number. The reference describes it the same way. It is closer in kind to a tissue extract than to the single, precisely defined peptides elsewhere in the directory, including thymosin alpha-1.
Where thymalin comes from
Thymalin came out of Soviet military medicine in the 1970s, from the work of Vyacheslav Morozov and Vladimir Khavinson. Their approach was to isolate short peptides from specific organs and use them to support the matching organ system, an idea they called peptide bioregulation. Thymalin is the thymus member of that family. Its relatives include the pineal-gland peptides that led to Epitalon, which is why the two share a research history.
The work continued at what became the St. Petersburg Institute of Bioregulation and Gerontology, and Khavinson's group has published on these peptides from the 1970s to the present. That single-program origin is both the strength and the limit of thymalin's evidence: a long, consistent body of research from one school of thought, without much independent replication in the West.
Organ-specific peptides
Thymalin
Epitalon
How it works
The thymus is where T-cells, a core part of the immune system, learn to do their job. Thymalin's peptides are described as helping regulate that maturation and restore immune balance, in effect topping up a gland that naturally winds down with age.
Modern laboratory work has looked at the thymalin peptide complex in human immune cells. In those studies the peptides pushed monocytes and macrophages toward a calmer, less inflammatory state, lowering the release of inflammatory messengers like TNF and IL-6. [2]
.svg)
The reference also describes effects on gene expression and blood-cell production. Those trace to the bioregulator literature and are better understood as the proposed mechanism than as settled findings, so we present them as where the research points.
What the research shows
Thymalin's evidence is real, and it is unusual. It is not thin the way a brand-new research peptide's is, but it is concentrated in one research program and published mostly in Russian journals, and it is light on the large Western trials that would settle its case in general medicine.
The most striking human study followed 266 older adults over six to eight years. Those given thymalin, together with a pineal-peptide preparation, showed improvements across immune, cardiovascular and metabolic measures, fewer respiratory infections, and lower mortality over the follow-up period than the untreated group. It is a genuine, published clinical study, and it is the same study cited on our Epitalon page, because the two peptides were tested together. We report it honestly, including its limits: it comes from a single research group, its design would not meet the standard of a modern controlled trial, and it has not been independently repeated in the West. Alongside it, recent laboratory studies give the anti-inflammatory mechanism modern, independent support at the cell level.
The reference for this peptide also cites very large patient counts in cancer-support and infection settings. We have not carried those specific figures, because we could not tie them to a verifiable primary source. What we can stand behind is the multi-year geroprotection study and the modern mechanism work, and the honest summary is this: a real but single-school evidence base, promising and internally consistent, still waiting for large independent trials.
Immune restoration and aging
A multi-year human study (with a pineal peptide)
Improved immune and health measures; lower mortality over follow-up
Real human data, single research program [1]
Anti-inflammatory mechanism
Modern human cell studies
Calmer monocyte and macrophage activity; lower TNF and IL-6
Early, independent lab support [2]
Infection and cancer-treatment support
Russian clinical literature
Reported benefits; specific figures not independently verified
Described, not settled
General immune support
Clinical experience
A quiet, long-term background role
Clinical observation (our practice)
How strong is the evidence
Tier words only. The honest shape here: real human data, but from one research program, plus modern lab support and our own background use.
Thymalin has a long track record for tolerability. Across decades of Russian clinical use it has been described as well tolerated, without a reported signal for cancer-causing or gene-damaging effects, and Dr. Koniver's own experience matches: he considers it very safe and uses it as a long-term background peptide.
A few honest cautions apply. Thymalin is made from calf (bovine) thymus tissue, so anyone with an allergy to bovine or animal-derived products needs to be screened for that. Because it acts on the immune system, there is a sensible theoretical caution about using it when the immune system is already overactive, as in autoimmune disease, so those situations call for physician judgment and monitoring. We avoid it in pregnancy and breastfeeding for lack of data. And because it is a complex extract that reaches the wellness market through research and compounding channels rather than as an approved product, quality and sourcing genuinely matter.
Regulatory status
Regulatory information current as of 13 August 2026. This is a summary, not legal or medical advice, and status can change.
United States
Not FDA-APPROVED
Not approved by the FDA for any medical use; available only through research and compounding channels. It has never been part of the US compounding review that placed other peptides on a restricted list - like the other obscure research-market peptides here, it sits outside that process. Verify current status.
Russia and Eastern Europe
APPROVED IN RUSSIA
Approved and used in Russian clinical medicine for decades as an immune-supporting agent, and used elsewhere in Eastern Europe. That real-world history is part of why it is taken seriously despite the thin Western trial record.
Sport (WADA)
Not Named - Verify
Not named on the WADA Prohibited List. Because it lacks broad regulatory approval, the List's catch-all category for non-approved substances could still apply to athletes in tested sport where it is unapproved, so anyone subject to anti-doping programs should verify current status with their governing body rather than assume it is allowed.
Regulatory information current as of 13 August 2026. Confirm the WADA position and current US status at publication.
Common questions
It is a peptide extract from calf thymus gland, a complex of short peptides rather than a single molecule, developed in Russia to support immune function, especially as the thymus gland declines with age.
Usually not, and that is expected. Dr. Koniver compares it to a vitamin D3 supplement: it works quietly in the background on the immune system, so people do not report a noticeable effect. Its value is as a long-term foundational peptide, not a peptide you feel day to day.
No. It is not approved in the United States and is available only through research and compounding channels. It is, however, an approved medicine in Russia, where it has been used clinically for decades. The regulatory section above has the detail.
Both support the thymus and the immune system, and we use them together. The key difference is what they are: thymosin alpha-1 is a single, precisely defined synthetic peptide, while thymalin is an extract, a mixture of thymic peptides. They are cousins in purpose, not the same kind of molecule.
Related peptides in this directory
References
- Khavinson VKh, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinol Lett. 2003;24(3-4):233-240. PMID 14523363.
- Avolio F, Martinotti S, Khavinson VK, et al. Peptides regulating proliferative activity and inflammatory pathways in the monocyte/macrophage THP-1 cell line. Int J Mol Sci. 2022;23(7):3607. PMID 35408963.
- Thymalin (thymus peptide complex), CAS 79621-14-0; a heterogeneous complex of short thymic peptides with no single molecular formula; molecular weight range approximately 1,000 to 10,000 daltons.
This page is for informational and educational purposes and does not constitute medical advice, diagnosis, or treatment. Thymalin is not approved by the FDA for any use in the United States and is available only through research and compounding channels; it is an approved medicine in Russia. Statements describing how Dr. Koniver and the Koniver Wellness team use thymalin reflect clinical experience and judgment, which is not the same as controlled clinical evidence. Nothing here is a substitute for consultation with a qualified healthcare provider. Peptide therapy at Koniver Wellness is provided under physician supervision after appropriate screening, and the availability of any given peptide depends on its regulatory and supply status. Regulatory information is current as of the date shown and may have changed; verify with official sources or a licensed practitioner in your jurisdiction.
INTERESTED IN PEPTIDES?
START WITH THE RIGHT QUESTIONS.
Understand what peptides can and cannot do, what the evidence actually says, and whether physician-guided peptide therapy makes sense for you.